目的 分析遼寧省腫瘤醫(yī)院抗腫瘤藥物的使用情況,為臨床合理應用抗腫瘤藥物提供參考。方法 對2012—2014年遼寧省腫瘤醫(yī)院抗腫瘤藥物的應用種類、劑型、銷售金額進行統(tǒng)計分析。結果 抗腫瘤藥物的銷售總金額呈逐年上升趨勢,細胞毒類抗腫瘤藥物的銷售金額一直排名第1位;劑型中注射劑的構成比一直居第1位;多西他賽、吉西他濱、來曲唑的銷售金額一直占據前3位。結論 臨床應選擇適合的抗腫瘤藥物,提高患者生存率和生活質量,促進抗腫瘤藥物的合理應用。

Objective To analyze the usage of anticancer drugs in Liaoning Cancer Hospital and Institute, and to provide reference for rational use of anticancer drugs. Methods The applied category, dosage form, and consumption sum of anticancer drugs in Liaoning Cancer Hospital and Institute from 2012 to 2014 were analyzed statistically. Results The consumption sum of the anticancer drugs increased year by year. Consumption sum of cytotoxic drugs ranked the first all the time. The constituent ratio of injections ranked the first all along. Consumption sum of docetaxel, gemcitabine, and letrozole were firmly at the top three. Conclusion Clinicians should select appropriate anticancer drugs, and improve survival and quality of life for patients, and promote the rational use of anticancer drugs.